Jerald C Sadoff Selected Research

AERAS-402

1/2017	Safety and Immunogenicity of Adenovirus 35 Tuberculosis Vaccine Candidate in Adults with Active or Previous Tuberculosis. A Randomized Trial.
6/2010	The novel tuberculosis vaccine, AERAS-402, induces robust and polyfunctional CD4+ and CD8+ T cells in adults.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jerald C Sadoff Research Topics

Disease

12	Tuberculosis (Tuberculoses) 01/2017 - 08/2007
5	Infections 01/2014 - 05/2008
2	Pulmonary Tuberculosis 08/2014 - 01/2010
1	Hematuria 01/2017
1	Otitis Media 11/2003
1	Breakthrough Infections 04/2002
1	Chickenpox 04/2002

Drug/Important Bio-Agent (IBA)

15	VaccinesIBA 01/2017 - 04/2002
2	AERAS-402IBA 01/2017 - 06/2010
1	Tuberculosis VaccinesIBA 01/2017
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2014
1	env Gene ProductsIBA 01/2012
1	Biomarkers (Surrogate Marker)IBA 06/2009
1	CytokinesIBA 06/2009
1	AntigensIBA 11/2008
1	Polysaccharides (Glycans)IBA 11/2003
1	Conjugate VaccinesIBA 11/2003
1	Membrane Proteins (Integral Membrane Proteins)IBA 11/2003
1	Hepatitis B Vaccines (Hepatitis B Vaccine)IBA 11/2003
1	EnzymesIBA 04/2002
1	ImmunosorbentsIBA 04/2002
1	AntibodiesIBA 04/2002
1	Chickenpox Vaccine (Vaccine, Varicella)IBA 04/2002
1	Glycoproteins (Glycoprotein)IBA 04/2002

Therapy/Procedure

1	Therapeutics 01/2014